Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia.


Autoria(s): Hudu,Shuaibu A.; Harmal,Nabil S.; Saeed,Mohammed I.; Alshrari,Ahmad S.; Malik,Yasmin A.; Niazlin,Mohd T.; Hassan,Roshida; Sekawi,Zamberi
Cobertura

Origin of publication: Uganda

Data(s)

15/10/2016

Resumo

Background: Occult hepatitis B infections are becoming a major global threat, but the available data on its prevalence in various parts of the world are often divergent. Objective: This study aimed to detect occult hepatitis B virus in hepatitis B surface antigen-negative serum using anti-HBc as a marker of previous infection. Patient and Methods: A total of 1000 randomly selected hepatitis B surface antigen-negative sera from blood donors were tested for hepatitis B core antibody and hepatitis B surface antibody using an ELISA and nested polymerase chain reaction was done using primers specific to the surface gene (S-gene). Results: Of the 1000 samples 55 (5.5%) were found to be reactive, of which 87.3% (48/55) were positive for hepatitis B surface antibody, indicating immunity as a result of previous infection however, that does not exclude active infection with escaped mutant HBV. Nested PCR results showed the presence of hepatitis B viral DNA in all the 55 samples that were positive for core protein, which is in agreement with the hepatitis B surface antibody result. Conclusion: This study reveals the 5.5% prevalence of occult hepatitis B among Malaysian blood donors as well as the reliability of using hepatitis B core antibody in screening for occult hepatitis B infection in low endemic, low socioeconomic settings.

Formato

html

Identificador

http://www.bioline.org.br/abstract?id=hs16086

Idioma(s)

en

Publicador

Makerere University Medical School

Relação

http://www.bioline.org.br/hs

Direitos

Copyright 2016 - African Health Sciences

Fonte

African Health Sciences (ISSN: 1680-6905) Vol 16 Num 3

Palavras-Chave #Hepatitis B; surface antigen; core antibody; polymerase chain reaction; occult hepatitis B infection
Tipo

AA